HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

OPEN ACCESS ARTICLE

This Article Free via Open Access: OA OA Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schäffler, A. Articles by Büchler, C. Search for Related Content PubMed PubMed Citation Articles by Schäffler, A. Articles by Büchler, C.

TISSUE-SPECIFIC STEM CELLS

Concise Review: Adipose Tissue-Derived Stromal Cells—Basic and Clinical Implications for Novel Cell-Based Therapies

Department of Internal Medicine I, University of Regensburg, Regensburg, Germany

Key Words. Adipocyte • Adipose tissue • Mesenchymal stem cell • Tissue engineering • Cell therapy

Correspondence: Andreas Schäffler, M.D., Department of Internal Medicine I, University of Regensburg, D-93042 Regensburg, Germany. Telephone: 0-049-941-944-7009; Fax: 0-049-941-944-7019; e-mail: andreas.schaeffler{at}klinik.uni-regensburg.de

Received September 19, 2006; accepted for publication December 1, 2006.


Compared with bone marrow-derived mesenchymal stem cells, adipose tissue-derived stromal cells (ADSC) do have an equal potential to differentiate into cells and tissues of mesodermal origin, such as adipocytes, cartilage, bone, and skeletal muscle. However, the easy and repeatable access to subcutaneous adipose tissue and the simple isolation procedures provide a clear advantage. Since extensive reviews focusing exclusively on ADSC are rare, it is the aim of this review to describe the preparation and isolation procedures for ADSC, to summarize the molecular characterization of ADSC, to describe the differentiation capacity of ADSC, and to discuss the mechanisms and future role of ADSC in cell therapy and tissue engineering. An initial effort has also been made to differentiate ADSC into hepatocytes, endocrine pancreatic cells, neurons, cardiomyocytes, hepatocytes, and endothelial/vascular cells. Whereas the lineage-specific differentiation into cells of mesodermal origin is well understood on a molecular basis, the molecular key events and transcription factors that initially allocate the ADSC to a lineage-specific differentiation are almost completely unknown. Decoding these molecular mechanisms is a prerequisite for developing novel cell therapies.

Disclosure of potential conflicts of interest is found at the end of this article.

This article has been cited by other articles:

				D. Sheyn, G. Pelled, Y. Zilberman, F. Talasazan, J. M. Frank, D. Gazit, and Z. Gazit Nonvirally Engineered Porcine Adipose Tissue-Derived Stem Cells: Use in Posterior Spinal Fusion Stem Cells, April 1, 2008; 26(4): 1056 - 1064. [Abstract] [Full Text] [PDF]

				P. Aguiari, S. Leo, B. Zavan, V. Vindigni, A. Rimessi, K. Bianchi, C. Franzin, R. Cortivo, M. Rossato, R. Vettor, et al. High glucose induces adipogenic differentiation of muscle-derived stem cells PNAS, January 29, 2008; 105(4): 1226 - 1231. [Abstract] [Full Text] [PDF]

				D. J. Duncker, A. Uitterdijk, and W. J. Van der Giessen Fat is not all bad: how to make good use of adipose tissue Eur. Heart J., November 1, 2007; 28(21): 2565 - 2567. [Full Text] [PDF]